Composition
- Active ingredients
- SIPONIMOD 2MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SIPONIMOD 2MG · TabletANDA218228-003 · Tentative approval
- SIPONIMOD 0.25MG · TabletANDA218228-001 · Tentative approval
- SIPONIMOD 1MG · TabletANDA218228-002 · Tentative approval
- SIPONIMOD EQ 2MG BASE · TabletANDA218444-003 · Discontinued
- SIPONIMOD EQ 0.25MG BASE · TabletANDA218444-001 · Discontinued
- SIPONIMOD EQ 1MG BASE · TabletANDA218444-002 · Discontinued
- SIPONIMOD 1MG · TabletANDA218393-003 · Tentative approval
- SIPONIMOD 0.25MG · TabletANDA218393-001 · Tentative approval
- SIPONIMOD 2MG · TabletThis page
- SIPONIMOD EQ 2MG BASE · TabletANDA218459-003 · Discontinued
- SIPONIMOD EQ 0.25MG BASE · TabletANDA218459-001 · Discontinued
- SIPONIMOD EQ 1MG BASE · TabletANDA218459-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA218393.
At a glance
- Brand name
- Siponimod
- Dosage form
- Tablet
- Applicant
- DR Reddys Labs LTD
- Status
- Tentative approval
- FDA approval
- 5 Jun 2025
- Application
- ANDA218393-002